1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. VIVOS THERAPEUTICS INC

Vivos Therapeutics Inc

XNAS: VVOS

Download real time

3.53 -0.02 (-0.56%)

43.79% Fall from 52W High

31,921 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
11S
10W
3O
0T
20.8

Market Cap

Low in industry
-1.7

PE TTM

Negative PE TTM
-0.1

PEG TTM

PEG TTM is negative
2.7

Price to Book

Below industry Median
0.4

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Vivos Therapeutics Inc is on 28 Mar 2025 for the purpose of Vivos Therapeutics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Vivos Therapeutics Inc

The latest disclosure was made by Kirk R. Huntsman in Vivos Therapeutics Inc where a trade of 315,421 Stock Option (Right to Buy) done was reported to US exchanges on Nov. 26, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kirk R. Huntsman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Nov 2024 315,421 364,755 - - Stock Option (Right to Buy)
Bradford Amman K. Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Nov 2024 149,533 180,533 - - Stock Option (Right to Buy)
Leonard J. Sokolow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 4,000 7,467 - - Stock Option (Right to Buy)
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 15,000 31,667 - - Stock Option (Right to Buy)
Anja Krammer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 4,000 7,067 - - Stock Option (Right to Buy)
Matthew Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 4,000 7,067 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 20,000 49,334 - - Stock Option (Right to Buy)
Ralph E. Green Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 4,000 7,067 - - Stock Option (Right to Buy)
Mark F. Lindsay Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 4,000 7,067 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.53 per share. 20 Jun 2023 14,000 86,521 - 0.5 7,420 Common Stock
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.52 per share. 15 Jun 2023 21 57,521 - 0.5 11 Common Stock
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.53 per share. 15 Jun 2023 5,000 72,521 - 0.5 2,650 Common Stock
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.54 per share. 15 Jun 2023 10,000 67,521 - 0.5 5,400 Common Stock
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.49 per share. 14 Jun 2023 10,000 57,500 - 0.5 4,900 Common Stock
R. Kirk Huntsman Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.50 per share. 23 Dec 2022 20,000 47,500 - 0.5 10,000 Common Stock
Mark F. Lindsay Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 30,000 76,667 - - Stock Option (Right to Buy)
Ralph E. Green Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 30,000 76,667 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 150,000 483,334 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 333,334 333,334 - - Stock Option (Right to Buy)
Anja Krammer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 30,000 76,667 - - Stock Option (Right to Buy)
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 200,000 500,001 - - Stock Option (Right to Buy)
Leonard J. Sokolow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 30,000 76,667 - - Stock Option (Right to Buy)
Matthew Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2022 30,000 76,667 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.83 per share. 31 May 2022 4,000 27,500 - 1.8 7,320 Common Stock
R. Kirk Huntsman Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.03 per share. 31 May 2022 8,000 23,500 - 2.0 16,240 Common Stock
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 50,000 50,000 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 125,000 125,000 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 4.31 per share. 21 Sep 2021 5,000 15,500 - 4.3 21,550 Common Stock
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2021 100,000 100,000 - - Stock Option (Right to Buy)
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2021 50,000 50,000 - - Stock Option (Right to Buy)
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2021 83,334 83,334 - - Stock Option (Right to Buy)
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2021 16,667 16,667 - - Stock Option (Right to Buy)
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.00 per share. 17 Aug 2021 5,000 10,500 - 3 15,000 Common Stock
Ralph E. Green Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2021 30,000 46,667 - - Stock Option (Right to Buy)
G. Dave Singh Director, Chief Medical Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2021 30,000 46,667 - - Stock Option (Right to Buy)
Matthew Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2021 30,000 46,667 - - Stock Option (Right to Buy)
Anja Krammer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2021 30,000 46,667 - - Stock Option (Right to Buy)
Leonard J. Sokolow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2021 30,000 46,667 - - Stock Option (Right to Buy)
Mark F. Lindsay Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2021 30,000 46,667 - - Stock Option (Right to Buy)
Bradford K. Amman Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 5.29 per share. 25 May 2021 1,000 2,000 - 5.3 5,290 Common Stock
R. Kirk Huntsman Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.38 per share. 25 May 2021 4,000 5,500 - 5.4 21,520 Common Stock
Bradford K. Amman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 100,000 200,001 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters